what is nash disease - Sports Zone
Reuters: Genfit could bring NASH liver disease treatment to market in 2019 Paris (Reuters) - French biopharmaceutical company Genfit said on Monday it is to launch a phase 3 study of its treatment for liver disease NASH by year-end as part of an accelerated approval ... NASH is also known as metabolic dysfunction associated steatohepatitis (MASH). In 2023, global liver disease medical societies and patient groups came together to rename the disease, with the goal of ...
Understanding the Context
WAVY-TV: Fatty Liver Alliance Champions for International NASH Day - A Wake-Up Call Against Liver Disease - An Escalating Threat The Fatty Liver Alliance raises awareness about the risks, causes and complications of fatty liver disease and helps those already diagnosed with NAFLD and NASH by advocating for access to approved ... Fatty Liver Alliance Champions for International NASH Day - A Wake-Up Call Against Liver Disease - An Escalating Threat Seeking Alpha: Madrigal Pharmaceuticals Announces New Data from the Phase 3 MAESTRO-NASH Study of Rezdiffra™ (resmetirom) Presented at the EASL Congress Madrigal Pharmaceuticals Announces New Data from the Phase 3 MAESTRO-NASH Study of Rezdiffra™ (resmetirom) Presented at the EASL Congress